Sirios Capital Management L P Invests $423,000 in Kenvue Inc. (NYSE:KVUE)

Sirios Capital Management L P acquired a new stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 19,796 shares of the company's stock, valued at approximately $423,000.

Several other large investors also recently modified their holdings of KVUE. Kiley Juergens Wealth Management LLC lifted its holdings in shares of Kenvue by 1.9% during the fourth quarter. Kiley Juergens Wealth Management LLC now owns 27,110 shares of the company's stock valued at $579,000 after acquiring an additional 500 shares during the period. Principle Wealth Partners LLC lifted its holdings in Kenvue by 3.7% during the 4th quarter. Principle Wealth Partners LLC now owns 14,194 shares of the company's stock valued at $303,000 after purchasing an additional 500 shares during the last quarter. White Pine Capital LLC increased its holdings in shares of Kenvue by 1.0% during the fourth quarter. White Pine Capital LLC now owns 54,572 shares of the company's stock worth $1,165,000 after buying an additional 542 shares in the last quarter. Deseret Mutual Benefit Administrators raised its stake in shares of Kenvue by 29.0% in the fourth quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company's stock valued at $54,000 after acquiring an additional 568 shares during the last quarter. Finally, SRS Capital Advisors Inc. boosted its holdings in shares of Kenvue by 67.4% in the 4th quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock worth $30,000 after acquiring an additional 571 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on KVUE shares. Citigroup boosted their price objective on Kenvue from $21.00 to $22.00 and gave the stock a "neutral" rating in a research note on Monday, April 14th. Piper Sandler increased their price objective on shares of Kenvue from $24.00 to $27.00 and gave the stock an "overweight" rating in a report on Monday, February 24th. UBS Group dropped their target price on shares of Kenvue from $23.00 to $21.00 and set a "neutral" rating for the company in a research note on Friday, February 7th. Evercore ISI started coverage on shares of Kenvue in a research note on Monday, March 24th. They set an "in-line" rating and a $25.00 price target on the stock. Finally, Canaccord Genuity Group boosted their price objective on shares of Kenvue from $24.00 to $29.00 and gave the stock a "buy" rating in a research report on Wednesday, March 5th. Eight research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Kenvue presently has an average rating of "Hold" and a consensus target price of $24.42.

Kenvue Stock Down 0.1 %

NYSE KVUE traded down $0.02 during trading hours on Monday, reaching $23.00. 3,148,298 shares of the company's stock were exchanged, compared to its average volume of 17,064,356. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. The company has a market capitalization of $44.12 billion, a price-to-earnings ratio of 43.37, a price-to-earnings-growth ratio of 2.62 and a beta of 1.02. The company's 50-day moving average is $23.03 and its two-hundred day moving average is $22.45. Kenvue Inc. has a one year low of $17.67 and a one year high of $24.46.

Kenvue (NYSE:KVUE - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. On average, analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th will be paid a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.57%. The ex-dividend date is Wednesday, May 14th. Kenvue's dividend payout ratio is presently 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.